Acute cardiovascular events and malignancies risk in rheumatoid arthritis patients treated with tofacitinib or TNF inhibitors, a nationwide cohort study: RELATION study
Cardiology
Rheumatology
Oncology
SNDS
communication-orale
Auteurs : Jacques-Eric Gottenberg, Nadir Mammar, Meriem Kessouri, Jeremie Rudant, Nada Assi, Benjamin Grenier, Julien Kirchgesner
Date de publication : 11 December 2022